Triple-Negative Breast Cancer Research and Education Act of 2025

Hozzl · 2025-04-01T08:06:22Z

Explore the details of House Bill 1806 Triple-Negative Breast Cancer Research and Education Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

4/1/2025, 8:06 AM

Summary of Bill HR 1806

Bill 119 HR 1806, also known as the Triple-Negative Breast Cancer Research and Education Act, aims to support research and education efforts specifically focused on triple-negative breast cancer. This type of breast cancer is known for being more aggressive and harder to treat than other forms of the disease.

The bill seeks to allocate funding for research initiatives that will help improve our understanding of triple-negative breast cancer, as well as develop more effective treatment options. Additionally, the legislation aims to enhance education and awareness surrounding this particular type of breast cancer, in order to better inform patients and healthcare providers.

Overall, the Triple-Negative Breast Cancer Research and Education Act is designed to address the unique challenges posed by triple-negative breast cancer and ultimately improve outcomes for those affected by this disease.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1806

Bill HR 1806 is currently in the status of Bill Introduced since March 3, 2025. Bill HR 1806 was introduced during Congress 119 and was introduced to the House on March 3, 2025. Bill HR 1806's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 3, 2025